Health News Archive - June 03, 2005
Exposure to high levels of airplane noise may be linked to delayed reading abilities and memory problems among youngsters, a new study finds.
A combination of chemotherapy drugs can increase the five-year survival rate of women with node-positive breast cancer by about 7 percent, a new study finds.
Treating obesity-related disorders costs as much or more than illnesses caused by aging, smoking and problem drinking.
SACRAMENTO, Calif., June 3 /PRNewswire/ -- As summer quickly approaches and the temperature begins to rise, the Dairy Council of California and Mealsmatter.org would like to encourage parents and kids to download recipes for refreshing healthy snacks that are easy to make during the summer months.
Most women are less forgiving of other women who lack comforting skills than of men who lack such skills, according to new Purdue University research on interpersonal relationships.
Binding gold nanoparticles to a specific antibody for cancer cells could make cancer detection much easier, say medical researchers from the University of California, San Francisco and Georgia Institute of Technology.
According to a study published in the American Gastroenterological Association (AGA) journal Gastroenterology, women with a high dietary intake of vitamin B6 over several years have a decreased risk of colorectal cancer (CRC).
A University of Alberta research team has discovered important new information they hope will lead to more effective treatments for pulmonary arterial hypertension (PAH)--a deadly form of high blood pressure in the pulmonary arteries caused by uncontrolled cell growth. Therapies are currently limited for a disease that can lead to heart failure and death within a few years.
Researchers open a new direction for research and treatment.
Currently, no medical treatment exists for nonalcoholic steatohepatitis (NASH), inflammation of the liver associated with the accumulation of fat in the liver. Recent studies indicate that NASH can result in scarring of the liver in up to 40 percent of people with the disease and cirrhosis (irreversible, advanced scarring of the liver) in approximately 25 percent of people with NASH. Researchers at Northwestern Memorial Hospital have launched a clinical trial to see if Pentoxifylline, a drug that has shown success decreasing inflammation of the liver in people with alcohol-related liver disease, can stop the progression of NASH.